APA

Wolff F. C., Dillenburg T. L., Venzon Antunes M., Linden R., Comparsi Wagner S. & Verza S. G. (20180625). Characterization of imatinib mesylate formulations distributed in South American countries: Determination of genotoxic impurities by UHPLC-MS/MS and dissolution profile. : Biomedical chromatography : BMC.

Chicago

Wolff Fernanda Caroline, Dillenburg Thaís Luise, Venzon Antunes Marina, Linden Rafael, Comparsi Wagner Sandrine and Verza Simone G. 20180625. Characterization of imatinib mesylate formulations distributed in South American countries: Determination of genotoxic impurities by UHPLC-MS/MS and dissolution profile. : Biomedical chromatography : BMC.

Harvard

Wolff F. C., Dillenburg T. L., Venzon Antunes M., Linden R., Comparsi Wagner S. and Verza S. G. (20180625). Characterization of imatinib mesylate formulations distributed in South American countries: Determination of genotoxic impurities by UHPLC-MS/MS and dissolution profile. : Biomedical chromatography : BMC.

MLA

Wolff Fernanda Caroline, Dillenburg Thaís Luise, Venzon Antunes Marina, Linden Rafael, Comparsi Wagner Sandrine and Verza Simone G. Characterization of imatinib mesylate formulations distributed in South American countries: Determination of genotoxic impurities by UHPLC-MS/MS and dissolution profile. : Biomedical chromatography : BMC. 20180625.